Reimbursed with a limitationOriginator productATC C10BA06

Ezetimib Rosuvastatin Spirig HC

Ezetimib Rosuvastatin Spirig HC is an originator product from Spirig HealthCare AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 39.55 to CHF 120.95 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Spirig HealthCare AG
ATC code
C10BA06
IT group
07.12 Blutlipidsenkende Mittel
Active substances
Ezetimibum, Rosuvastatinum
Preparation type
Originator product
On the SL since
01/09/2021
Last price change
01/06/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Ezetimib Rosuvastatin Spirig HC Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 10/5 mgBlist 30 StkCHF 21.27CHF 39.5501/06/2025B7680680690055
Filmtabl 10/5 mgBlist 100 StkCHF 70.90CHF 93.5001/06/2025B7680680690062
Filmtabl 10/10 mgBlist 30 StkCHF 25.05CHF 43.6501/09/2021B7680680690017
Filmtabl 10/10 mgBlist 100 StkCHF 83.50CHF 107.2501/09/2021B7680680690024
Filmtabl 10/20 mgBlist 30 StkCHF 28.83CHF 47.7501/09/2021B7680680690031
Filmtabl 10/20 mgBlist 100 StkCHF 96.11CHF 120.9501/09/2021B7680680690048

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/06/2025

EZETIMIB ROSUVASTATIN SPIRIG HC wird als Ersatztherapie bei erwachsenen Patienten vergütet, die bereits Ezetimib und Rosuvastatin als separate Tabletten in der gleichen Dosierungsstärke erhalten und die Kriterien entsprechend der Limitierungen der Ezetimib- und Rosuvastatin-Monopräparate erfüllen.

More preparations in this group

FAQ

Is Ezetimib Rosuvastatin Spirig HC covered by Swiss health insurance?

Yes, but only under conditions. Ezetimib Rosuvastatin Spirig HC is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Ezetimib Rosuvastatin Spirig HC cost in Switzerland?

The public price is the maximum price set by the FOPH and for Ezetimib Rosuvastatin Spirig HC ranges from CHF 39.55 to CHF 120.95 per pack. The ex-factory price ranges from CHF 21.27 to CHF 96.11. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com